Literature DB >> 18604626

Contribution of I Kr and I K1 to ventricular repolarization in canine and human myocytes: is there any influence of action potential duration?

Norbert Jost1, Károly Acsai, Balázs Horváth, Tamás Bányász, István Baczkó, Miklós Bitay, Gábor Bogáts, Péter P Nánási.   

Abstract

BACKGROUND: The aim of the present work was to study the profile of the rapid delayed rectifier potassium current (I (Kr)) and the inward rectifier potassium current (I (K1)) during ventricular repolarization as a function of action potential duration and rate of repolarization.
METHODS: Whole cell configuration of the patch clamp technique was used to monitor I (Kr) and I (K1) during the action potential plateau and terminal repolarization. Action potentials recorded at various cycle lengths (0.4-5 s) and repolarizing voltage ramps having various slopes (0.5-3 V/s) were used as command signals. I (Kr) and I (K1) were identified as difference currents dissected by E-4031 and BaCl(2), respectively.
RESULTS: Neither peak amplitudes nor mean values of I (Kr) and I (K1) recorded during the plateau of canine action potentials were influenced by action potential duration. The membrane potential where I (Kr) and I (K1) peaked during the terminal repolarization was also independent of action potential duration. Similar results were obtained in undiseased human ventricular myocytes, and also in canine cells when I (Kr) and I (K1) were evoked using repolarizing voltage ramps of various slopes. Action potential voltage clamp experiments revealed that the peak values of I (Kr), I (K1), and net outward current during the terminal repolarization were independent of the pacing cycle length within the range of 0.4 and 5 s.
CONCLUSIONS: The results indicate that action potential configuration fails to influence the amplitude of I (Kr) and I (K1) during the ventricular action potential in dogs and humans, suggesting that rate-dependent changes in action potential duration are not likely related to rate-dependent alterations in I (Kr) or I (K1) kinetics in these species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18604626     DOI: 10.1007/s00395-008-0730-3

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  16 in total

1.  Asynchronous activation of calcium and potassium currents by isoproterenol in canine ventricular myocytes.

Authors:  Ferenc Ruzsnavszky; Bence Hegyi; Kornél Kistamás; Krisztina Váczi; Balázs Horváth; Norbert Szentandrássy; Tamás Bányász; Péter P Nánási; János Magyar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-02-25       Impact factor: 3.000

2.  Quantitative comparison of cardiac ventricular myocyte electrophysiology and response to drugs in human and nonhuman species.

Authors:  Thomas O'Hara; Yoram Rudy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-09       Impact factor: 4.733

Review 3.  Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Vassilios J Bezzerides; Donghui Zhang; William T Pu
Journal:  Circ J       Date:  2016-12-03       Impact factor: 2.993

4.  High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.

Authors:  Junyi Ma; Liang Guo; Steve J Fiene; Blake D Anson; James A Thomson; Timothy J Kamp; Kyle L Kolaja; Bradley J Swanson; Craig T January
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-02       Impact factor: 4.733

5.  Role of action potential configuration and the contribution of C²⁺a and K⁺ currents to isoprenaline-induced changes in canine ventricular cells.

Authors:  N Szentandrássy; V Farkas; L Bárándi; B Hegyi; F Ruzsnavszky; B Horváth; T Bányász; J Magyar; I Márton; P P Nánási
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

6.  Mexiletine-like cellular electrophysiological effects of GS967 in canine ventricular myocardium.

Authors:  Tamás Hézső; Muhammad Naveed; Csaba Dienes; Dénes Kiss; János Prorok; Tamás Árpádffy-Lovas; Richárd Varga; Erika Fujii; Tanju Mercan; Leila Topal; Kornél Kistamás; Norbert Szentandrássy; János Almássy; Norbert Jost; János Magyar; Tamás Bányász; István Baczkó; András Varró; Péter P Nánási; László Virág; Balázs Horváth
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

7.  Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias.

Authors:  Maaike Hoekstra; Christine L Mummery; Arthur A M Wilde; Connie R Bezzina; Arie O Verkerk
Journal:  Front Physiol       Date:  2012-08-31       Impact factor: 4.566

8.  Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation.

Authors:  Thomas O'Hara; László Virág; András Varró; Yoram Rudy
Journal:  PLoS Comput Biol       Date:  2011-05-26       Impact factor: 4.475

9.  Eag Domains Regulate LQT Mutant hERG Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Qiang-Ni Liu; Matthew C Trudeau
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

Review 10.  The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening.

Authors:  Jaffar M Khan; Alexander R Lyon; Sian E Harding
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.